Financial statements Swisspharma Polska
Balance sheet of Swisspharma Polska
Company age:
Age:
7 y. 8 m. 26 d.
Share capital:
Share capital:
5 000 PLN
Balance sheet data of SWISSPHARMA POLSKA
|
Year
|
2017
|
2019
|
2020
|
|---|---|---|---|
| Total assets | 386 310,07 | 725 819,88 | 396 453,58 |
| A. Fixed assets | 146 259,37 | 157 942,37 | 9 675,15 |
| B. Current assets | 240 050,70 | 567 877,51 | 386 778,43 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 |
| Total liabilities | 386 310,07 | 725 819,88 | 396 453,58 |
| A. Equity | 84 758,61 | 87 796,85 | -67 104,25 |
| B. Liabilities and provisions for liabilities | 301 551,46 | 638 023,03 | 463 557,83 |
| I. Long-term liabilities | 220 500,00 | 371 826,00 | 371 826,00 |
| II. Short-term liabilities | 80 961,31 | 263 965,70 | 91 731,83 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.